-+ 0.00%
-+ 0.00%
-+ 0.00%

Susquehanna Maintains Negative on RXO, Raises Price Target to $11

Benzinga·01/08/2026 14:22:33
語音播報
Susquehanna analyst Bascome Majors maintains RXO (NYSE:RXO) with a Negative and raises the price target from $10 to $11.